P151: Improvement of virologic response and liver elasticity in HCV‐patients after liver transplantation through treatment with the new direct‐acting antivirals

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|S2|94-95

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.S2, 2015-06, pp. : 94-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HBV reactivation in patients with HCV/HBV cirrhosis on treatment with direct‐acting antivirals

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 72-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prophylaxis of HCV reinfection and direct‐acting antiviral agents during liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 1527-6465, Iss. 10, 2015-10 ,pp. : 1327-1329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐Effectiveness of New Direct‐Acting Antivirals to Prevent Post–Liver Transplant Recurrent Hepatitis

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 15, Iss. 7, 2015-07 ,pp. : 1817-1826

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimal duration of pre‐liver transplantation anti‐hepatitis C virus treatment with direct‐acting agent sofosbuvir

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 6, 2015-06 ,pp. : 1776-1776

John Wiley & Sons Inc

Access to resources Recommend Favorite